NOVARTIS – DERMATOLOGY WEBINAR

Meeting Objectives

• To provide an overview of IL-17 and its implications
• To highlight the diagnosis and management of Hidradenitis Suppurativa

Programme

6:30pm – 6:35pm     Welcome & Greetings– Mrs. Janice Simpson-Spencer – Novartis Country         Manager

6:35pm– 6:40pm     Introduction of Moderator – Mrs Sophia McKenzie – Novartis Business Coordinator

6:40pm – 7:10pm     Opening Remarks and Presentation on the Multi-Modal IL 17 – Dr. Delansie Lawrence

7:10pm –7:15pm     Questions & Answers

7:15pm – 7:20pm    Introduction of Speaker – Moderator

7:20pm – 8:05 pm   Presentation on The Diagnosis and Management of Hidradenitis Suppurativa – Dr. Rokeisha Clare-Kleinbussink – Consultant Dermatologist

8:05pm – 8:20 pm   Questions and Answers

8:20pm – 8:25pm    Vote of thanks – Mr. Jason Spence – Novartis Medical Representative